Cellular and molecular basis of proximal small intestine disorders.
Bildstein T. et al, (2024), Nat Rev Gastroenterol Hepatol
Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial.
de Cates AN. et al, (2024), Br J Psychiatry, 1 - 8
Amplification of autoimmune organ damage by NKp46-activated ILC1.
Biniaris-Georgallis S-I. et al, (2024), Nature
Anteromedial knee osteoarthritis (AMOA) evaluated with magnetic resonance imaging (MRI): a cohort study of 100 patients.
Bunyoz KI. et al, (2024), Arch Orthop Trauma Surg, 144, 3439 - 3447
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial.
Sheppard JP. et al, (2024), Lancet Healthy Longev, 5, e563 - e573
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
Chandran M. et al, (2024), Osteoporos Int, 35, 1337 - 1358
Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
Griffin H. et al, (2024), N Engl J Med, 391, 434 - 441
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.
Jakobsen NA. et al, (2024), Cell Stem Cell, 31, 1127 - 1144.e17
Short-chain fatty acids: linking diet, the microbiome and immunity.
Mann ER. et al, (2024), Nat Rev Immunol, 24, 577 - 595
Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells.
Sacristán C. et al, (2024), Cell Rep, 43
Mucosal signatures of pathogenic T cells in HLA-B*27+ anterior uveitis and axial spondyloarthritis.
Paley MA. et al, (2024), JCI Insight, 9
Mucosal Healing with Vedolizumab in Patients with Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled Trial.
Jairath V. et al, (2024), Clin Gastroenterol Hepatol
Ro60-Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases.
Mahla RS. et al, (2024), Int J Mol Sci, 25
Leveraging cutting-edge transcriptomics to inform precision therapeutic targeting for soft tissue joint disease.
Ackerman JE. and Dakin SG., (2024), J Orthop Res